// App-Quantinova.ai

: TRENDS IN EXTENDED-DURATION POSTOPERATIVE VENOUS THROMBOEMBOLISM PROPHYLAXIS FOLLOWING RADICAL CYSTECTOMY AMONG COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES

Researchers

Presenter

  • Timothy Lyon

Principal Investigators

  • Nilay Shah

  • Paras Shah

  • Lindsey Sangaralingham

  • Dennis Asante

  • R. Houston Thompson

  • Matthew Tollefson

  • R. Jeffrey Karnes

  • Igor Frank

  • Stephen Boorjian

Medical Centers

  • N/A

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved